Literature DB >> 29758181

Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.

Yang Zhang1, Difan Zheng1, Juntao Xie1, Yuan Li2, Yiyang Wang3, Chenguang Li4, Jiaqing Xiang1, Yawei Zhang1, Hong Hu1, Yihua Sun1, Haiquan Chen5.   

Abstract

BACKGROUND: There is currently no consensus regarding the optimal postoperative follow-up strategy for patients with completely resected non-small cell lung cancer (NSCLC). We aimed to develop web-based nomograms to precisely predict site-specific postoperative recurrence in patients with NSCLC and to guide individual surveillance strategies including when to follow up and what diagnostic tests to perform.
METHODS: We investigated the pattern of recurrence in a series of 2,017 patients with NSCLC (squamous cell carcinoma and nonlepidic invasive adenocarcinoma) who underwent complete surgical resection at Fudan University Shanghai Cancer Center (development cohort), and developed web-based clinicopathologic prediction models for conditional risk of site-specific recurrence based on Cox regression. The variables used in the analysis included sex, age, smoking history, tumor size, tumor histology, lymphovascular invasion, visceral pleural invasion, and pathologic TNM stage. A separate cohort of 3,308 patients with NSCLC from Shanghai Chest Hospital was used for external validation.
RESULTS: In the development cohort and the external validation cohort for the established nomograms to predict overall recurrence, thorax recurrence, abdomen recurrence, neck recurrence, brain recurrence, and bone recurrence, the C-statistics of Harrell et al were 0.743 and 0.748, 0.728 and 0.703, 0.760 and 0.749, 0.779 and 0.757, 0.787 and 0.784, and 0.777 and 0.739, respectively. The calibration plots showed optimal agreement between nomogram-predicted 3-year recurrence-free survival and actual 3-year recurrence-free survival.
CONCLUSIONS: These user-friendly nomograms can precisely predict site-specific recurrence in patients with completely resected NSCLC, based on clinicopathologic features. They may help physicians to make individual postoperative follow-up plans.
Copyright © 2018 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  diagnostic imaging; lung cancer; surgery oncology; thoracic surgery

Mesh:

Year:  2018        PMID: 29758181     DOI: 10.1016/j.chest.2018.04.040

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition).

Authors:  Wenhua Liang; Kaican Cai; Chun Chen; Haiquan Chen; Wentao Fang; Junke Fu; Xiangning Fu; Shugeng Gao; Jian Hu; Yunchao Huang; Ganning Jiang; Wenjie Jiao; Shanqing Li; Gaofeng Li; Hecheng Li; Hui Li; Xiaofei Li; Naixin Liang; Deruo Liu; Hongxu Liu; Jun Liu; Lunxu Liu; Yang Liu; Qingquan Luo; Haitao Ma; Weimin Mao; Zhongmin Peng; Guibin Qiao; Guoguang Shao; Lijie Tan; Qunyou Tan; Qun Wang; Changli Wang; Qingchen Wu; Shidong Xu; Songtao Xu; Lin Xu; Yue Yang; Fenglei Yu; Baijiang Zhang; Lanjun Zhang; Bo Zhao; Xiuyi Zhi; Alessandro Brunelli; René Horsleben Petersen; Chia-Chuan Liu; Biagio Ricciuti; Giulio Metro; Alessandro Tuzi; Matteo B Suter; Matthew Evison; Nobuhiko Seki; Shinji Sasada; Takhiro Izumo; William Chi-Shing Cho; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2019-12

2.  A nomogram model of postoperative prognosis for metastatic lung adenocarcinoma: A study based on the SEER database.

Authors:  Xiaowei Tie; Lianlian Chen; Xiaomin Li; Wenjuan Zha; Yangchen Liu
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

3.  Patterns and risks of postoperative recurrence in completely resected EGFR-mutant non-small cell lung cancer: prognostic significance of routine immunohistochemical markers.

Authors:  Jianjiao Ni; Tiantian Guo; Yuan Li; Xi Yang; Yida Li; Liqing Zou; Li Chu; Xiao Chu; Shuyan Li; Luxi Ye; Yawei Zhang; Zhengfei Zhu
Journal:  Transl Lung Cancer Res       Date:  2019-12

4.  A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.

Authors:  Yuan Zeng; Nicholas Mayne; Chi-Fu Jeffrey Yang; Jun Liu; Fei Cui; Jingpei Li; Wenhua Liang; Jianxing He
Journal:  Transl Lung Cancer Res       Date:  2021-04

5.  The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma.

Authors:  Lu Yang; Jing Zhang; Guangjian Yang; Haiyan Xu; Jing Lin; Lin Shao; Junling Li; Changyuan Guo; Yanru Du; Lei Guo; Xin Li; Han Han-Zhang; Chenyang Wang; Shannon Chuai; Junyi Ye; Qiaolin Kang; Hao Liu; Jianming Ying; Yan Wang
Journal:  Theranostics       Date:  2020-06-18       Impact factor: 11.556

6.  Development and External Validation of Web-Based Models to Predict the Prognosis of Remnant Gastric Cancer after Surgery: A Multicenter Study.

Authors:  Qi-Yue Chen; Qing Zhong; Jun-Feng Zhou; Xian-Tu Qiu; Xue-Yi Dang; Li-Sheng Cai; Guo-Qiang Su; Dong-Bo Xu; Zhi-Yu Liu; Ping Li; Kai-Qing Guo; Jian-Wei Xie; Qiu-Xian Chen; Jia-Bin Wang; Teng-Wen Li; Jian-Xian Lin; Shuang-Ming Lin; Jun Lu; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Wei Lin; Qing-Liang He; Chao-Hui Zheng; Chang-Ming Huang
Journal:  J Oncol       Date:  2019-04-10       Impact factor: 4.375

7.  Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy.

Authors:  Yang Wo; Hongxia Yang; Yinling Zhang; Jinshan Wo
Journal:  Front Oncol       Date:  2019-12-11       Impact factor: 6.244

8.  A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma.

Authors:  Li Sun; Juan Li; Xiaomeng Li; Xuemei Yang; Shujun Zhang; Xue Wang; Nan Wang; Kanghong Xu; Xinquan Jiang; Yi Zhang
Journal:  Front Genet       Date:  2021-06-14       Impact factor: 4.599

9.  Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.

Authors:  Shenghua Dong; Jun Liang; Wenxin Zhai; Zhuang Yu
Journal:  Am J Clin Oncol       Date:  2020-09       Impact factor: 2.787

10.  Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.

Authors:  Chen-Fei Wu; Jia-Wei Lv; Li Lin; Yan-Ping Mao; Bin Deng; Wei-Hong Zheng; Dan-Wan Wen; Yue Chen; Jia Kou; Fo-Ping Chen; Xing-Li Yang; Zi-Qi Zheng; Zhi-Xuan Li; Si-Si Xu; Jun Ma; Ying Sun
Journal:  Cancer Commun (Lond)       Date:  2020-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.